Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Reinecke, H.
Right arrow Articles by Schaefer, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinecke, H.
Right arrow Articles by Schaefer, R. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 2218-2221
© 2003 European Renal Association-European Dialysis and Transplant Association

Editorial Comment

Percutaneous coronary interventions in patients with mild to moderate chronic renal failure: to dilate or not to dilate?

Holger Reinecke1 and Roland M. Schaefer2

1Department of Cardiology and Angiology and 2Department of Nephrology, Hospital of the University of Münster, Münster, Germany

Correspondence and offprint requests to: Dr H. Reinecke, Medizinische Klinik und Poliklinik C, Universitätsklinikum Münster, D-48129 Münster, Germany. Email: reinech@uni-muenster.de

Keywords: chronic renal failure; outcome; percutaneous coronary intervention

The first 150 words of the full text of this article appear below.

Introduction

Worldwide, the incidence of chronic kidney disease has risen relentlessly over recent years due to an increasing prevalence of diabetes mellitus and arteriosclerotic vascular disease [1–4]. A further increase in the number of patients with chronic renal failure has to be expected in the coming years [4,5]. Thus, adequate management of these patients will become a more and more pressing issue in clinical medicine.

It is well known from patients with end-stage renal failure that a large number will develop cardiovascular disease over time and that coronary heart disease (CHD), myocardial infarction and congestive heart failure represent major causes of morbidity and mortality in these patients [6]. Moreover, chronic renal failure not yet requiring renal replacement therapy has not been recognized—at least by many cardiologists—as an important cardiovascular risk factor. However, a few but very consistent recent studies provided good . . . [Full Text of this Article]

Chronic renal failure and cardiovascular risk

PCI in chronic renal failure

PCI vs bypass surgery: and the winner is ...

Conclusions


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?